Solko W. Schalm
#132,796
Most Influential Person Now
Solko W. Schalm's AcademicInfluence.com Rankings
Solko W. Schalmmedical Degrees
Medical
#2248
World Rank
#2656
Historical Rank
Gastroenterology
#37
World Rank
#39
Historical Rank
Epidemiology
#385
World Rank
#404
Historical Rank
Solko W. Schalmphilosophy Degrees
Philosophy
#6543
World Rank
#9593
Historical Rank
Logic
#3695
World Rank
#4892
Historical Rank
Download Badge
Medical Philosophy
Solko W. Schalm's Degrees
- Doctorate Medicine University of California, San Francisco
- PhD Epidemiology University of California, Berkeley
Why Is Solko W. Schalm Influential?
(Suggest an Edit or Addition)Solko W. Schalm's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Morbidity and mortality in compensated cirrhosis type C: a retrospective follow-up study of 384 patients. (1997) (1438)
- Pegylated interferon alfa-2b alone or in combination with lamivudine for HBeAg-positive chronic hepatitis B: a randomised trial (2005) (1160)
- A proposed system for the nomenclature of hepatitis C viral genotypes (1994) (1100)
- Acute liver failure: redefining the syndromes (1993) (877)
- Sustained Virologic Response and Clinical Outcomes in Patients with Chronic Hepatitis C and Advanced Fibrosis (2007) (618)
- Lamivudine and alpha interferon combination treatment of patients with chronic hepatitis B infection: a randomised trial (2000) (513)
- Subclinical hepatic encephalopathy impairs daily functioning (1998) (493)
- Survival and prognostic indicators in hepatitis B surface antigen-positive cirrhosis of the liver. (1992) (411)
- Occurrence of hepatocellular carcinoma and decompensation in western european patients with cirrhosis type B (1995) (405)
- Influence of hepatitis delta virus infection on morbidity and mortality in compensated cirrhosis type B (2000) (395)
- European collaborative study on factors influencing outcome after liver transplantation for hepatitis C. European Concerted Action on Viral Hepatitis (EUROHEP) Group. (1999) (349)
- Long‐term follow‐up of alpha‐interferon treatment of patients with chronic hepatitis B (2004) (332)
- Predictors of HBeAg loss after lamivudine treatment for chronic hepatitis B (2002) (317)
- Lamivudine treatment during pregnancy to prevent perinatal transmission of hepatitis B virus infection (2003) (304)
- Effect of hepatitis B and C virus infections on the natural history of compensated cirrhosis: a cohort study of 297 patients (2002) (300)
- Survival and prognostic factors in 366 patients with compensated cirrhosis type B: a multicenter study (1994) (274)
- Increased risk of hepatocellular carcinoma among patients with hepatitis C cirrhosis and diabetes mellitus (2008) (270)
- Lamivudine resistance inimmunocompetent chronic hepatitis B (1997) (261)
- Treatment with Peg-Interferon α-2b for HBeAg-Positive Chronic Hepatitis B: HBsAg Loss Is Associated with HBV Genotype (2006) (255)
- Ribavirin enhances the efficacy but not the adverse effects of interferon in chronic hepatitis C. Meta-analysis of individual patient data from European centers. (1997) (241)
- Suicide associated with alfa-interferon therapy for chronic viral hepatitis. (1994) (237)
- Interferon (IFN)-gamma-inducible protein-10: association with histological results, viral kinetics, and outcome during treatment with pegylated IFN-alpha 2a and ribavirin for chronic hepatitis C virus infection. (2006) (230)
- IP‐10 predicts viral response and therapeutic outcome in difficult‐to‐treat patients with HCV genotype 1 infection (2006) (225)
- Acute Exacerbation of Chronic Hepatitis B Virus Infection After Withdrawal of Lamivudine Therapy (2000) (215)
- Screening of subclinical hepatic encephalopathy. (2000) (205)
- Ten-year neonatal hepatitis B vaccination program, The Netherlands, 1982-1992: protective efficacy and long-term immunogenicity. (1997) (200)
- Delayed clearance of serum HBsAg in compensated cirrhosis B: relation to interferon alpha therapy and disease prognosis (1998) (193)
- Hemostasis and fibrinolysis in severe liver failure and their relation to hemorrhage (1986) (184)
- Effectiveness of interferon alfa on incidence of hepatocellular carcinoma and decompensation in cirrhosis type C. European Concerted Action on Viral Hepatitis (EUROHEP). (1997) (182)
- Intravenous glycyrrhizin for the treatment of chronic hepatitis C: A double‐blind, randomized, placebo‐controlled phase I/II trial (1999) (181)
- Long term clinical outcome of chronic hepatitis C patients with sustained virological response to interferon monotherapy (2004) (180)
- Benign versus malignant hepatic nodules: MR imaging findings with pathologic correlation. (2002) (178)
- Durability of HBeAg seroconversion following antiviral therapy for chronic hepatitis B: relation to type of therapy and pretreatment serum hepatitis B virus DNA and alanine aminotransferase (2003) (177)
- A replicon-based bioassay for the measurement of interferons in patients with chronic hepatitis C. (2003) (176)
- Prognosis of Ursodeoxycholic Acid-Treated Patients with Primary Biliary Cirrhosis. Results of a 10-Yr Cohort Study Involving 297 Patients (2006) (163)
- International, multicenter, randomized, controlled study comparing dynamically individualized versus standard treatment in patients with chronic hepatitis C. (2005) (162)
- High prevalence of autoimmune hepatitis among patients with primary sclerosing cholangitis. (2000) (157)
- Interferon alfa for chronic hepatitis B infection: Increased efficacy of prolonged treatment (1999) (153)
- Objective measurement of hepatic encephalopathy by means of automated EEG analysis. (1984) (152)
- Systemic and intrahepatic interferon‐gamma‐inducible protein 10 kDa predicts the first‐phase decline in hepatitis C virus RNA and overall viral response to therapy in chronic hepatitis C (2010) (138)
- The prognostic significance of subclinical hepatic encephalopathy (2000) (138)
- Glycyrrhizin-induced reduction of alt in european patients with chronic hepatitis C (2001) (132)
- Screening and early treatment of migrants for chronic hepatitis B virus infection is cost-effective. (2010) (131)
- Cyclical etidronate in the prevention of bone loss in corticosteroid-treated primary biliary cirrhosis. A prospective, controlled pilot study. (1997) (129)
- Contrasting features and responses to treatment of severe chronic active liver disease with and without hepatitis BS antigen. (1976) (124)
- Identification of more than one mutation in the hepatitis B virus polymerase gene arising during prolonged lamivudine treatment. (1998) (123)
- Review article: glycyrrhizin as a potential treatment for chronic hepatitis C. (1998) (121)
- Liver transplantation and hepatitis C (2002) (120)
- Auxiliary partial liver transplantation for end-stage chronic liver disease. (1988) (117)
- Inhibitory effect of 9-(2-phosphonylmethoxyethyl)-adenine (PMEA) on human and duck hepatitis B virus infection. (1993) (117)
- Subclinical hepatic encephalopathy. (1996) (116)
- IL28B polymorphisms predict reduction of HCV RNA from the first day of therapy in chronic hepatitis C. (2011) (114)
- Failure of neonatal hepatitis B vaccination: the role of HBV-DNA levels in hepatitis B carrier mothers and HLA antigens in neonates. (1994) (113)
- Flares in chronic hepatitis B patients induced by the host or the virus? Relation to treatment response during Peg-interferon α-2b therapy (2005) (113)
- Dynamics of hepatitis B virus infection in vivo. (1997) (112)
- The prognostic significance of subclinical hepatic encephalopathy. (2000) (112)
- Peginterferon alpha‐2b is safe and effective in HBeAg‐positive chronic hepatitis B patients with advanced fibrosis (2007) (112)
- Survival and prognostic factors in 366 patients with compensated cirrhosis type B: a multicenter study. The Investigators of the European Concerted Action on Viral Hepatitis (EUROHEP). (1994) (109)
- Safety of interferon and ribavirin therapy in haemodialysis patients with chronic hepatitis C: results of a pilot study. (2001) (106)
- Budesonide or prednisone in combination with ursodeoxycholic acid in primary sclerosing cholangitis: a randomized double-blind pilot study (2000) (104)
- Hepatitis B reactivation after lamivudine (1995) (102)
- Age- and region-specific hepatitis B prevalence in Turkey estimated using generalized linear mixed models: a systematic review (2011) (98)
- Inhibitory effects of acyclic nucleoside phosphonates on human hepatitis B virus and duck hepatitis B virus infections in tissue culture (1994) (96)
- Generic and disease-specific health related quality of life in non-cirrhotic, cirrhotic and transplanted liver patients: a cross-sectional study (2003) (95)
- HLA determinants in chronic active liver disease: possible relation of HLA-Dw3 to prognosis. (2008) (90)
- Early prediction of response in interferon monotherapy and in interferon-ribavirin combination therapy for chronic hepatitis C: HCV RNA at 4 weeks versus ALT. (1999) (90)
- The treatment effect of alpha interferon in chronic hepatitis B is independent of pre-treatment variables. Results based on individual patient data from 10 clinical controlled trials. European Concerted Action on Viral Hepatitis (Eurohep). (1994) (88)
- Molecular cytogenetic evaluation of virus‐associated and non‐viral hepatocellular carcinoma: analysis of 26 carcinomas and 12 concurrent dysplasias (2000) (87)
- DOUBLE-BLIND STUDY OF LEUCOCYTE INTERFERON ADMINISTRATION IN CHRONIC HBsAg-POSITIVE HEPATITIS (1980) (86)
- Long-term outcome of hepatitis B e antigen-positive patients with compensated cirrhosis treated with interferon alfa. European Concerted Action on Viral Hepatitis (EUROHEP). (1997) (83)
- Extracellular brain glutamate during acute liver failure and during acute hyperammonemia simulating acute liver failure: an experimental study based on in vivo brain dialysis. (1994) (82)
- Overt hepatic encephalopathy precipitated by zinc deficiency. (1991) (80)
- Biochemical and histological effects of 26 weeks of glycyrrhizin treatment in chronic hepatitis C: a randomized phase II trial. (2006) (78)
- High impact of migration on the prevalence of chronic hepatitis B in the Netherlands (2008) (78)
- Triple therapy with ursodeoxycholic acid, prednisone and azathioprine in primary biliary cirrhosis: a 1-year randomized, placebo-controlled study. (1998) (77)
- ACYCLOVIR ENHANCES THE ANTIVIRAL EFFECT OF INTERFERON IN CHRONIC HEPATITIS B (1985) (77)
- HCV-specific T-cell response in relation to viral kinetics and treatment outcome (DITTO-HCV project). (2007) (76)
- Failure of customary treatment in chronic active liver disease: causes and management. (1976) (75)
- Prednisone for chronic active liver disease: pharmacokinetics, including conversion to prednisolone. (1977) (74)
- Pegylated interferon alfa-2a (40 kD) and ribavirin in haemodialysis patients with chronic hepatitis C. (2007) (74)
- Therapy of hepatitis C: Patients with cirrhosis (1997) (72)
- Patterns of viral decline during PEG‐interferon alpha‐2b therapy in HBeAg‐positive chronic hepatitis B: Relation to treatment response (2006) (70)
- Diurnal serum levels of primary conjugated bile acids. Assessment by specific radioimmunoassays for conjugates of cholic and chenodeoxycholic acid. (1978) (69)
- Treatment of chronic hepatitis B virus infection - Dutch national guidelines. (2008) (69)
- Other clinical studyOccurrence of hepatocellular carcinoma and decompensation in Western European patients with cirrhosis type B (1995) (67)
- Sequence analysis of the 5' untranslated region in isolates of at least four genotypes of hepatitis C virus in The Netherlands (1994) (67)
- Paired measurements of quantitative hepatitis B virus DNA in saliva and serum of chronic hepatitis B patients: implications for saliva as infectious agent. (2004) (65)
- Bone mass in women with primary biliary cirrhosis: the relation with histological stage and use of glucocorticoids. (1990) (63)
- Retreatment of chronic hepatitis B e antigen–positive patients with recombinant interferon alfa‐2a (1999) (62)
- Ursodeoxycholic acid therapy for primary sclerosing cholangitis: results of a 2-year randomized controlled trial to evaluate single versus multiple daily doses. (1998) (61)
- The role of intrahepatic immune effector cells in inflammatory liver injury and viral control during chronic hepatitis B infection (2003) (61)
- Mitochondrial Injury (1997) (60)
- HLA antigens in patients with various courses after hepatitis B virus infection (1987) (59)
- Detection of hepatitis C virus RNA in patients with chronic hepatitis C virus infections during and after therapy with alpha interferon (1993) (59)
- Measurement of HBsAg to monitor hepatitis B viral replication in patients on alpha-interferon therapy. (1994) (58)
- Histological improvement in patients with chronic hepatitis B virus infection treated with lamivudine. (2008) (56)
- Oral prednisone for chronic active liver disease: dose responses and bioavailability studies. (1978) (55)
- Sequences of hepatitis B virus DNA in the serum and liver of patients with acute benign and fulminant hepatitis. (1987) (55)
- New nucleoside analogues for chronic hepatitis B. (2000) (55)
- Letters to the Editor: Lamivudine in the last 4 weeks of pregnancy to prevent perinatal transmission in highly viremic chronic hepatitis B patients (2000) (54)
- Molecular cytogenetic evaluation of virus-associated and non-viral hepatocellular carcinoma: analysis of 26 carcinomas and 12 concurrent dysplasias. (2000) (54)
- The Liver Disease Symptom Index 2.0; Validation of a Disease-Specific Questionnaire (2004) (54)
- BEHAVIOUR OF e ANTIGEN AND ANTIBODY DURING CHRONIC ACTIVE LIVER DISEASE RELATION TO HB ANTIGEN-ANTIBODY SYSTEM AND PROGNOSIS (1976) (52)
- Pharmacokinetics of intravenous glycyrrhizin after single and multiple doses in patients with chronic hepatitis C infection. (1999) (52)
- Diagnostic tools for the detection of subclinical hepatic encephalopathy: comparison of standard and computerized psychometric tests with spectral-EEG (1996) (52)
- Radioimmunoassay of bile acids: development, validation, and preliminary application of an assay for conjugates of chenodeoxycholic acid. (1977) (52)
- Recovery of failing liver after auxiliary heterotopic transplantation (1990) (52)
- Spontaneous disappearance of viral replication and liver cell inflammation in HBsAg‐positive chronic active hepatitis: Results of a placebo vs. interferon trial (1982) (50)
- Efficacy of interferon dose and prediction of response in chronic hepatitis C: Benelux study in 336 patients. (1998) (49)
- Analysis of intrahepatic HBV-specific cytotoxic T-cells during and after acute HBV infection in humans. (2006) (48)
- Effectiveness of interferon alfa on incidence of hepatocellular carcinoma and decompensation in cirrhosis type C (1997) (47)
- Hepatitis C virus genotypes: distribution and clinical significance in patients with cirrhosis type C seen at tertiary referral centres in Europe (2001) (47)
- Lamivudine in the last 4 weeks of pregnancy to prevent perinatal transmission in highly viremic chronic hepatitis B patients. (2000) (47)
- The diagnosis of cirrhosis: clinical relevance and methodology. (1997) (47)
- A reproducible model of acute hepatic failure by transient ischemia in the pig. (1987) (47)
- Clinical diagnosis of primary biliary cirrhosis: a classification based on major and minor criteria. (1983) (47)
- Lamivudine and intron a combination treatment in patients with chronic hepatitis B infection (1998) (46)
- Intrahepatic CD8+ T-lymphocyte response is important for therapy-induced viral clearance in chronic hepatitis B infection. (2005) (46)
- Co‐occurrence of HBsAg and anti‐HBs: Two consecutive infections or a sign of advanced chronic liver disease? (1982) (45)
- Different composition of intrahepatic lymphocytes in the immune‐tolerance and immune‐clearance phase of chronic hepatitis B (2006) (45)
- Clinical implications of lamivudine resistance by HBV (1997) (44)
- Failure of acyclovir to enhance the antiviral effect of alpha lymphoblastoid interferon on HBe-seroconversion in chronic hepatitis B. A multi-centre randomized controlled trial. (1992) (44)
- Genetic characteristics of hepatitis B virus genotypes as a factor for interferon‐induced HBeAg clearance (2007) (44)
- Hepatitis C virus genotypes: epidemiological and clinical associations (2008) (43)
- Sequence analysis of hepatitis C virus genotypes 1 to 5 reveals multiple novel subtypes in the Benelux countries. (1995) (43)
- Immunogenicity of standard and low dose vaccination using yeast-derived recombinant hepatitis B surface antigen in elderly volunteers. (1994) (43)
- Generic and disease-specific health related quality of life of liver patients with various aetiologies: A survey (2007) (43)
- Viral dynamics in chronic hepatitis B patients during lamivudine therapy. (2002) (42)
- Peg‐interferon improves liver histology in patients with HBeAg‐positive chronic hepatitis B: no additional benefit of combination with lamivudine (2006) (42)
- Prognostic factors and long-term effects of ursodeoxycholic acid on liver biochemical parameters in patients with primary biliary cirrhosis (1999) (42)
- Paired, quantitative measurements of hepatitis B virus DNA in saliva, urine and serum of chronic hepatitis B patients (2005) (42)
- Seizures associated with low-dose α-interferon (1990) (41)
- Polyarteritis nodosa associated with hepatitis B virus infection. The role of antiviral treatment and mutations in the hepatitis B virus genome. (2004) (40)
- Serum HBeAg quantitation during antiviral therapy for chronic hepatitis B (1997) (40)
- Molecular characteristics of hepatitis B virus genotype a confer a higher response rate to interferon treatment (2001) (40)
- Reduction of relapse rates by 18-month treatment in chronic hepatitis C. A Benelux randomized trial in 300 patients. (2004) (40)
- Endoscopic sclerotherapy for bleeding oesophagogastric varices secondary to extrahepatic portal vein obstruction in an adult Caucasian population (1998) (39)
- Flumazenil therapy for hepatic encephalopathy. A double-blind cross over study. (1995) (39)
- Combined treatment with ursodeoxycholic acid and prednisone in primary biliary cirrhosis. (1994) (39)
- Long-term clinical outcome and effect of glycyrrhizin in 1093 chronic hepatitis C patients with non-response or relapse to interferon (2006) (38)
- Treatment of chronic hepatitis C virus infection - Dutch national guidelines. (2008) (38)
- Antiviral agents in hepatitis B virus transfected cell lines: inhibitory and cytotoxic effect related to time of treatment. (1995) (38)
- FIBROBLAST INTERFERON IN HBsAg-POSITIVE CHRONIC ACTIVE HEPATITIS (1977) (38)
- Hepatitis C: Viral kinetics (1997) (38)
- Long-term effects of treatment and response in patients with chronic hepatitis C on quality of life. An international, multicenter, randomized, controlled study (2012) (37)
- The influence of baseline characteristics on viral dynamic parameters in chronic hepatitis B patients treated with lamivudine. (2002) (37)
- Viral dynamics during tenofovir therapy in patients infected with lamivudine‐resistant hepatitis B virus mutants (2005) (37)
- Hepatitis C viral kinetics in difficult to treat patients receiving high dose interferon and ribavirin. (2001) (35)
- A non-invasive fibrosis score predicts treatment outcome in chronic hepatitis C virus infection (2008) (35)
- Potential impact of long‐term nucleoside therapy on the mortality and morbidity of active chronic hepatitis B (2009) (35)
- Changes in anti-viral effectiveness of interferon after dose reduction in chronic hepatitis c patients: a case control study (2001) (34)
- Chronic hepatitis C: Interferon retreatment of relapsers. A meta‐analysis of individual patient data (1999) (34)
- Chronic hepatitis B: a critical appraisal of current approaches to therapy. (2006) (34)
- Hepatitis B Vaccination in Down's Syndrome and Other Mentally Retarded Patients (1984) (34)
- Prevention of hepatitis B infection in newborns through mass screening and delayed vaccination of all infants of mothers with hepatitis B surface antigen. (1989) (33)
- Estimating the future health burden of chronic hepatitis B and the impact of therapy in Spain (2008) (33)
- Flucloxacillin-associated hepatic injury. (2008) (32)
- ‘Pseudo‐aldosteronism’ induced by intravenous glycyrrhizin treatment of chronic hepatitis C patients (2001) (32)
- Improvement of hepatitis B-associated glomerulonephritis after antiviral combination therapy. (1989) (32)
- Successful Treatment with Peginterferon alfa-2b of HBeAg-positive HBV Non-Responders to Standard Interferon or Lamivudine (2006) (31)
- The cost-effectiveness of treating chronic hepatitis B patients in a median endemic and middle income country (2012) (31)
- Flow cytometry of fine‐needle‐aspiration biopsies: a new method to monitor the intrahepatic immunological environment in chronic viral hepatitis (2005) (31)
- Transmission of hepatitis B virus among heart transplant recipients during endomyocardial biopsy procedures. (1998) (31)
- Peginterferon for the treatment of chronic hepatitis B in the era of nucleos(t)ide analogues. (2008) (30)
- Hepatitis B vaccination and preterm infants. (1993) (30)
- γ‐Glutamyltransferase and rapid virological response as predictors of successful treatment with experimental or standard peginterferon‐α‐2b in chronic hepatitis C non‐responders (2007) (30)
- Severe chronic active liver disease (1977) (30)
- Original contributionEffect of hepatitis B and C virus infections on the natural history of compensated cirrhosis: a cohort study of 297 patients (2002) (29)
- Endoscopic sclerotherapy compared with no specific treatment for the primary prevention of bleeding from esophageal varices. A randomized controlled multicentre trial [ISRCTN03215899] (2003) (29)
- Interferon‐α and zidovudine combination therapy for chronic hepatitis B: Results of a randomized, placebo‐controlled trial (1993) (29)
- Quantitative EEG analysis and evoked potentials to measure (latent) hepatic encephalopathy. (1992) (29)
- Early invasive prenatal diagnosis in HBsAg‐positive women (1994) (29)
- Low therapeutic value of D-penicillamine in a short-term prospective trial in primary biliary cirrhosis. (2008) (28)
- Immune response to hepatitis B vaccine in pregnant women receiving post-exposure prophylaxis. (1993) (28)
- Development of radioimmunoassays for prednisone and prednisolone. Application to studies of hepatic metabolism of prednisone. (1976) (28)
- Repeated courses of α-interferon for treatment of chronic hepatitis type B (1993) (28)
- Antiviral therapy of hepatitis C. (1997) (27)
- Immune response to hepatitis B vaccine in hemodialysis patients. (1987) (27)
- New treatment strategies in non-responder patients with chronic hepatitis C. (1999) (27)
- Late results of mesocaval interposition shunting for bleeding oesophageal varices (1987) (27)
- Selection of an entecavir-resistant mutant despite prolonged hepatitis B virus DNA suppression, in a chronic hepatitis B patient with preexistent lamivudine resistance: successful rescue therapy with tenofovir (2008) (27)
- Increased intragraft IL-15 mRNA expression after liver transplantation. (1998) (26)
- Antiviral effect of prolonged intermittent lymphoblastoid alpha interferon treatment in chronic hepatitis B. (1992) (26)
- Hyperammonemic coma after hepatectomy in germ-free rats (1978) (25)
- Proposal for routine antenatal screening at 14 weeks for hepatitis B surface antigen (1995) (25)
- Intravascular Coagulation in Liver Transplantation – Is It Present or Not? (1993) (25)
- Phenprocoumon-induced hepatitis mimicking non-A, non-B hepatitis. (1990) (25)
- Beneficial effects of Phyllanthus amarus for chronic hepatitis B, not confirmed. (1991) (24)
- The effect of pegylated interferon-alpha on the treatment of lamivudine resistant chronic HBeAg positive hepatitis B virus infection. (2006) (24)
- Does auxiliary heterotopic liver transplantation reverse hypersplenism and portal hypertension? (1991) (24)
- Low‐dose (2 μg) hepatitis B vaccination in medical students: Comparable immunogenicity for intramuscular and intradermal routes (1989) (24)
- Immunogenicity of 20 μg of recombinant DNA hepatitis B vaccine in healthy neonates: A comparison of three different vaccination schemes (1993) (23)
- Possible errors in sampling percutaneous liver biopsies for determination of trace element status: application to patients with primary biliary cirrhosis. (1981) (23)
- Hyperammonaemia and Helicobacter pylori (1995) (23)
- Human hepatic lymph nodes contain normal numbers of mature myeloid dendritic cells but few plasmacytoid dendritic cells. (2004) (23)
- THE APPEARANCE OF DONOR HEPARIN IN THE RECIPIENT AFTER REPERFUSION OF A LIVER GRAFT (1993) (22)
- Anti‐hepatitis B virus activity of a mixture of two monoclonal antibodies in an “inhibition in solution” assay (1995) (22)
- Pretreatment intrahepatic CD8+ cell count correlates with virological response to antiviral therapy in chronic hepatitis C virus infection. (2003) (22)
- Differential effects of fibroblast and leucocyte interferon in HBsAg positive chronic active hepatitis (1979) (22)
- A SIMPLE METHOD FOR SHORT‐TERM PRESERVATION OF A LIVER HOMOGRAFT1 (1969) (22)
- Comparison of a quantitative standardized HBV-DNA assay and a classical spot hybridization test in chronic active hepatitis B patients undergoing antiviral therapy. (1989) (22)
- Immune response after vaccination with recombinant hepatitis B vaccine as compared to that after plasma-derived vaccine. (1985) (22)
- Prevention and treatment of osteoporosis in primary biliary cirrhosis. (1999) (21)
- Alpha lymphoblastoid interferon and acyclovir for chronic hepatitis delta. (1991) (21)
- New aspects of heterotopic liver transplantation (1992) (21)
- Prognostic factors and long-term effects of ursodeoxycholic acid on liver biochemical parameters in patients with primary biliary cirrhosis. Dutch Multi-Centre PBC Study Group. (1999) (21)
- Intragraft IL-4 mRNA expression is associated with down-regulation of liver graft rejection. (1996) (21)
- Eurohep. A European Community sponsored concerted action on viral hepatitis: its rationale and execution. (1992) (21)
- High sustained virological response in chronic hepatitis C by combining induction and prolonged maintenance therapy (2003) (20)
- Clinical impact of lamivudine resistance in chronic hepatitis B. (1998) (20)
- Quantitative assessment of hepatitis B virus DNA in chronic hepatitis B: comparison of two solution hybridization assays (1993) (20)
- Hyperammonemic, ammonia-independent coma in experimental acute liver failure induced in the pig (1981) (20)
- Gamma-glutamyltransferase and rapid virological response as predictors of successful treatment with experimental or standard peginterferon-alpha-2b in chronic hepatitis C non-responders. (2007) (20)
- Long term response to interferon treatment in chronic hepatitis C patients is associated with a significant reduction in anti‐E1 envelope antibody titers (2000) (20)
- Passive-active immunisation of neonates of HBsAg positive carrier mothers: preliminary observations. (1984) (20)
- Cyclosporin A assay: conditions for sampling and processing of blood. (1985) (19)
- Effect of liquid diet on serum protein binding and prednisolone concentrations after oral prednisone. (1976) (19)
- Combination Therapy for Chronic Hepatitis B (2005) (19)
- Serial determination of type III procollagen amino propeptide serum levels in patients with histologically progressive and non-progressive primary biliary cirrhosis. (1992) (19)
- Auxiliary transplantation of part of the liver improves survival and provides metabolic support in pigs with acute liver failure. (1985) (19)
- Intrahepatic CD8 T‐lymphocytes and HBV core expression in relation to response to antiviral therapy for chronic hepatitis B patients (2004) (19)
- Anti-HBs after hepatitis B immunization with plasma-derived and recombinant DNA-derived vaccines: binding to mutant HBsAg. (2001) (18)
- Is combination therapy with lamivudine and interferon-alpha superior to monotherapy with either drug? (2001) (18)
- The treatment of hepatitis C: history, presence and future. (2004) (18)
- Hepatitis C virus genotypes: epidemiological and clinical associations. Benelux Study Group on Treatment of Chronic Hepatitis C. (1998) (18)
- Passive immunization of chronic hepatitis B patients on lamivudine therapy: a feasible issue? (2002) (18)
- Management of osteoporosis in primary biliary cirrhosis. (2000) (18)
- Management of hepatitis B virus infected health care workers based on HBV DNA levels. (2003) (17)
- DITTO-HCV early viral kinetics report - novel decline patterns in gen 1 but not gen 2–3 patients treated with PEG-interferon-alfa-2a and ribavirin (2002) (17)
- Graft regeneration and host liver atrophy after auxiliary heterotopic liver transplantation for chronic liver failure (1992) (17)
- Relation between treatment efficacy and cumulative dose of alpha interferon in chronic hepatitis B. European Concerted Action on Viral Hepatitis (Eurohep). (1996) (17)
- Rapid genotyping of hepatitis C virus RNA‐isolates obtained from patients residing in Western Europe (1995) (17)
- Hepatitis B revaccination of neonates with inadequate response after primovaccination. (1992) (17)
- Retreatment of hepatitis C non-responsive to Interferon. A placebo controlled randomized trial of Ribavirin monotherapy versus combination therapy with Ribavirin and Interferon in 121 patients in the Benelux [ISRCTN53821378] (2003) (16)
- A surgical model of fulminant hepatic failure in the rabbit: different effects of end-to-side versus small-diameter side-to-side portacaval shunt. (1987) (16)
- 2011 IL28B POLYMORPHISM IS SIGNIFICANTLY CORRELATED WITH IFN ANTI-VIRAL EFFECTIVENESS ALREADY ON FIRST DAY OF PEGYLATED INTERFERON-α AND RIBAVIRIN THERAPY OF CHRONIC HCV INFECTION (2010) (16)
- Low dose intradermal vaccination against hepatitis B in mentally retarded patients. (1988) (16)
- The intrahepatic immune response during chronic hepatitis B infection can be monitored by the fine-needle aspiration biopsy technique. (2003) (16)
- A simple technique for endotracheal intubation in rabbits (1987) (16)
- Orthotopic liver transplantation: an experimental study on mechanisms of hemorrhagic diathesis and thrombosis. (1975) (16)
- Diurnal serum levels of primary conjugated bile acids 1 (1978) (15)
- Heterotopic vs. orthotopic liver transplantation for chronic liver disease: A case‐control comparison of short‐term and long‐term outcomes (2005) (15)
- Fulminant hepatic failure: to transplant or not to transplant. (1991) (15)
- Fatal hepatitis C virus infection in a heart transplant recipient detectable by polymerase chain reaction only. (1994) (15)
- Benelux multicentre trial of alpha interferon treatment for chronic hepatitis C: standard v high dose treatment monitored by biochemical and virological markers (interim analysis). Benelux Multicentre Trial Study Group. (1993) (15)
- Hepatitis B vaccination of haemodialysis patients: randomized controlled trial comparing plasma‐derived vaccine with and without pre‐S 2 antigen (1990) (14)
- Severe allergic eczema due to pegylated alpha-interferon may abate after switching to daily conventional alpha-interferon. (2007) (14)
- Zidovudine inhibits hepatitis B virus replication. (1992) (14)
- Prevention of recurrent variceal bleeding: non-surgical procedures. (1985) (14)
- Characteristics of the early phase of chronicity in acute hepatitis B infection (1999) (14)
- Detection of integration during active replication of hepatitis B virus in the liver (1985) (14)
- Anti-HBs levels in infants of hepatitis B carrier mothers after delayed active immunization with recombinant vaccine concomitant with DTP-polio vaccine: is there need for a second dose of HBIg? Dutch Study Group on Prevention of Neonatal Hepatitis B. (1994) (14)
- Can ursodeoxycholic acid induce disease remission in primary biliary cirrhosis? The Dutch Multicentre PBC Study Group. (1995) (14)
- Immune response to hepatitis B vaccine in drug addicts. (1983) (14)
- Severe chronic active hepatitis (autoimmune type) mimicked by coinfection of hepatitis C and human immunodeficiency viruses. (1991) (14)
- Immunogenicity of 20 micrograms of recombinant DNA hepatitis B vaccine in healthy neonates: a comparison of three different vaccination schemes. (1993) (13)
- Transjugular intrahepatic portosystemic shunt. Requiem for the surgical portosystemic shunt? (1993) (13)
- Flumazenil does not improve hepatic encephalopathy associated with acute ischemic liver failure in the rabbit (1990) (13)
- Repeated courses of alpha-interferon for treatment of chronic hepatitis type B. (1993) (13)
- Coagulation and fibrinolysis in the first human auxiliary partial liver transplantation in rotterdam (1988) (13)
- Incidence, characteristics and clinical impact of lamivudine resistance in chronic hepatitis B (1998) (13)
- Modelling of Early Viral Kinetics and Pegylated Interferon-α2b Pharmacokinetics in Patients with HBeAg-Positive Chronic Hepatitis B (2007) (13)
- Seizures associated with low-dose alpha-interferon. (1990) (13)
- T-lymphocyte subpopulations in patients with various courses after hepatitis B virus infection. (1984) (13)
- Course of hepatitis B and D virus infection in auxiliary liver grafts in hepatitis B-positive patients. A light-microscopic and immunohistochemical study. (1992) (13)
- The role of auxiliary liver transplantation. (1987) (13)
- Hepatitis B vaccination of haemodialysis patients: randomized controlled trial comparing plasma‐derived vaccine with and without pre‐S2 antigen (1990) (12)
- Serum IgM in primary biliary cirrhosis. (1980) (12)
- Recurrent bleeding from cutaneous venous collaterals in portal hypertension. (1988) (12)
- Antiviral treatment for human immunodeficiency virus patients co-infected with hepatitis B virus: combined effect for both infections, an obtainable goal? (1999) (12)
- Lamivudine-interferon combination therapy for chronic hepatitis B: further support but no conclusive evidence. (2001) (12)
- Interferon‐alpha therapy for chronic hepatitis B: Early response related to pre‐treatment changes in viral replication (2001) (12)
- Hepatitis C 2002 guidelines: summary and annotations. (2003) (12)
- Immunosuppressive therapy for primary biliary cirrhosis. (1992) (12)
- New developments in antiviral therapy for chronic hepatitis B infection. (1995) (12)
- Hepatitis B virus DNA in serum of pregnant women with HBsAg and HBeAg or antibodies to HBe. (1984) (11)
- Intravenous glycyrrhizin for the treatment of chronic hepatitis C: a double‐blind placebo‐controlled randomized trial (1998) (11)
- Long-term follow-up of antiviral combination therapy in chronic hepatitis B. (1988) (10)
- FIBRINOLYSIS DETECTED BY THROMBELASTOGRAPHY IN HETEROTOPIC, AUXILLARY LIVER TRANSPLANTATION: EFFECT OF TISSUE-TYPE PLASMINOGEN ACTIVATOR (1988) (10)
- Chronic hepatitis B. (1990) (10)
- Continuous intravenous ammonia infusion as a model for the study of hepatic encephalopathy in rabbits. (1989) (10)
- Orthotopic liver transplantation after preservation without perfusion for up to six hours: A controlled trial evaluating different preservation fluids in dogs and pigs. (1975) (10)
- Effect of cyclosporine and cyclosporine plus prednisone in primary biliary cirrhosis. (1988) (10)
- Strategies for hepatic support in acute liver failure: Role of extracorporeal devices versus liver transplantation (1989) (9)
- Predicting treatment outcome following 24 weeks peginterferon α‐2a/ribavirin therapy in patients infected with HCV genotype 1: Utility of HCV‐RNA at day 0, day 22, day 29, and week 6 (2007) (9)
- Comparison of large‐pore membrane haemodialysis and cross‐dialysis in acute hepatic insufficiency in pigs (1983) (9)
- Doctor‐to‐patient transmission of viral hepatitis B: is it a problem, is there a solution? (2000) (9)
- Long‐term immune reactivity to pre‐S(2)‐antigen after acute hepatitis B infection (1989) (9)
- Doctor-to-patient transmission of Hepatitis B virus: the potential of antiviral therapy for prevention (2004) (9)
- Soluble intercellular adhesion molecule‐1 in primary biliary cirrhosis: effect of ursodeoxycholic acid and immunosuppressive therapy (1997) (9)
- Detection of HBV-DNA in liver biopsy and serum: its significance in the selection of hepatitis B patients for antiviral therapy. (1987) (9)
- Lymphoblastoid alpha-interferon weekly, daily and combined with acyclovir for chronic HBeAg-positive hepatitis. (1986) (9)
- Trans jugular Intrahepatic Portosystemic Shunt (1993) (8)
- Hepatitis C viral kinetics in plasma and peripheral blood mononuclear cells during pegylated interferon-alpha2a/ribavirin therapy. (2008) (8)
- In vivo immunization following virus suppression: a novel approach for inducing immune control in chronic hepatitis B * (2003) (8)
- Hepatitis in a patient with SLE: is it autoimmune hepatitis? (1996) (8)
- Peginterferon and Dose-Titrated Ribavirin for Hepatitis C-Associated Nephrotic Membranoproliferative Glomerulonephritis Type 1 (2005) (8)
- Evaluation of efficacy of antiviral therapy for chronic hepatitis C: a EUROHEP Consensus Report on response criteria (1996) (8)
- Relapse after treatment with peginterferon α-2b alone or in combination with lamivudine in HBeAg positive chronic hepatitis B (2007) (8)
- [483] PRESENCE OF BIOPSY-PROVEN HISTOLOGIC DAMAGE (NECROINFLAMMATION AND FIBROSIS) IS COMMON EVEN WHEN ALT IS LESS THAN 2 × ULN IN PATIENTS WITH CHRONIC HEPATITIS B (CHB) (2007) (8)
- Treatment of chronic active hepatitis. (2008) (8)
- Quantitative relationship between HBeAg and DNA polymerase activity in sera from patients with chronic active hepatitis during a three‐month period (1980) (8)
- Hyperammonemic coma after hepatectomy in germ-free rats. (1979) (8)
- Oesophageal varices: how reliable is a barium swallow? (1993) (8)
- Interferon-alpha and zidovudine combination therapy for chronic hepatitis B: results of a randomized, placebo-controlled trial. (1993) (8)
- Hepatitis C virus genotype: what does it tell us? (1995) (7)
- [Changes in the management of patients with side effects from the treatment of hepatitis C]. (2007) (7)
- A procedure for arterial blood sampling in the rabbit (1986) (7)
- Hepatitis C and cirrhosis (2000) (7)
- Low-dose (2 micrograms) hepatitis B vaccination in medical students: comparable immunogenicity for intramuscular and intradermal routes. (1989) (7)
- Survival and prognostic indicators in HBsAg-positive liver cirrhosis (1991) (7)
- Acyclovir, oral, intravenous and combined with interferon for chronic HBeAg-positive hepatitis. (1986) (7)
- Binding of the ligand [3H]MK-801 to the MK-801 binding site of the N-methyl-D-aspartate receptor during experimental encephalopathy from acute liver failure and from acute hyperammonemia in the rabbit (1993) (6)
- Endoscopic sclerotherapy anno 1985; established standard therapy? (1985) (6)
- Immunoprophylaxis to limit a hepatitis B epidemic among women undergoing in vitro fertilization. (1991) (6)
- Auxiliary heterotopic liver transplantation. (1988) (6)
- Oral pharmacokinetics of cyclosporin in patients with primary biliary Cirrhosis and patients with skin diseases (1992) (6)
- Intravenous monoclonal anti-HBS (m-anti-HBs) in chronic hepatitis B (HBV) patients treated with lamivudine (2000) (6)
- Cyclical etidronate in the prevention of corticosteroid induced bone loss in primary biliary cirrhosis (1995) (6)
- Objective measurement of hepatic encephalopathy in pigs by means of spectral analysis and evoked responses (1985) (6)
- Interferon-ribavirin combination therapy for chronic hepatitis C (1996) (5)
- Monomeric (7S) IgM in primary biliary cirrhosis. (1982) (5)
- HUMAN LIVER MYELOID DENDRITIC CELLS MATURATE IN VIVO INTO EFFECTOR DC WITH POOR ALLOGENEIC T-CELL STIMULATORY CAPACITY (2004) (5)
- PREVENTION OF HEPATITIS B TRANSMISSION AT BIRTH (1989) (5)
- Immunogenicity of two different dosages (10 and 5 μg) of recombinant DNA hepatitis B vaccine in healthy neonates (1994) (5)
- 192 Early viral kinetics prediction of sustained virological response after 1 or 4 weeks of PEG-interferon-ALFA-2A and ribavirin therapy (Ditto-HCV project) (2003) (5)
- A comparison between heterotopic and orthotopic liver transplantation in patients with end-stage chronic liver disease. (1991) (5)
- Long-term application of human polyclonal hepatitis-B immunoglobulin to prevent hepatic allograft infection. A review of the literature and presentation of five cases. (1993) (5)
- Summary of the first international symposium on viral hepatitis. (1999) (5)
- Neuronal and glial marker proteins in encephalopathy associated with acute liver failure and acute hyperammonemia in the rabbit (1993) (5)
- 446 Viral dynamics during PEG-interferon alone and in combination with lamivudine (2004) (4)
- Effect of naloxone on shock in a patient with fulminant hepatic failure. (1983) (4)
- Famciclovir treatment in lamivudine resistent chronic hepatitis B patients (1998) (4)
- Adding ribavirin to interferon α-2b for chronic hepatitis C infection increased virological response and nausea (1998) (4)
- Cyclical etidronate in the prevention of corticosteroid-induced bane loss in primary biliary cirrhosis (1995) (4)
- Treatment of chronic viral hepatitis. (1989) (4)
- Pseudo-Budd-Chiari Syndrome: decompensated alcoholic liver disease mimicking hepatic venous outflow obstruction. (2002) (4)
- Incidence of endotoxemia in pigs with ischemic hepatic necrosis treated by hemodialysis. Prevention of endotoxemia with lactulose. (1983) (4)
- Effect of daily versus twice daily high dose IFN and ribavirin treatment on HCV kinetics (2000) (4)
- Treatment of chronic hepatitis B. (1994) (4)
- Goals of Antiviral Therapy: Viral Clearance or ALT Normalization (1999) (4)
- The optimal timing of liver transplantation in patients with chronic cholestatic liver disease (2005) (4)
- Acute Hepatic Failure (1992) (3)
- Temporary disappearance of viral replication in hepatitis B surface antigen-positive, severe chronic active hepatitis. (1981) (3)
- Comparison of two techniques for detecting antibody to HBsAg during a hepatitis B vaccine study. (1985) (3)
- Soluble ICAM-1 in primary biliary cirrhosis (PBC) during combined treatment with ursodeoxycholic acid, prednisone and azathioprine (1995) (3)
- Treatment of HBeAg-Positive Chronic Hepatitis B with Conventional or Pegylated Interferon (2004) (3)
- Infections after auxiliary partial liver transplantation. Experiences in the first ten patients (1990) (3)
- Ip-10 Is Associated With Il28b Variation And Predicts The First Phase Decline Of Hcv Rna And Outcome Of Therapy In Chronic Hepatitis C (2010) (3)
- Reduction of relapse in chronic HCV. A benelux study in 300 patients (2001) (3)
- Encephalopathy from acute liver failure and from acute hyperammonemia in the rabbit. A clinical and biochemical study. (2008) (3)
- Immune responses during lamivudine/interferon-α combination therapy of chronic HBV infection (2000) (3)
- Cholescintigraphy with99mTc-diethyl-IDA for the detection of rejection of auxiliary liver transplants in pigs (2004) (3)
- Function of partial liver allografts after heterotopic transplantation. (1992) (3)
- Treatment of chronic hepatitis C: practical aspects. (1997) (3)
- Durability of hbeag seroconversion in chronic hepatitis B patients after lamivudine A-interferon or lamivudine A- interferon combination therapy (2001) (3)
- 45CaCl2 autoradiography in brain from rabbits with encephalopathy from acute liver failure or acute hyperammonemia (1994) (3)
- PREDICTION OF BLEEDING RISK BY HAEMOSTASIS TESTS (1988) (3)
- Hepatic encephalopathy following transjugular intrahepatic portosystemic shunt (TIPS): incidence, clinical course and risk factors (1996) (3)
- Hepatitis B vaccination in health care workers: assessment of simple guidelines. (1987) (3)
- [Chronic hepatitis-b-virus infections: new options for antiviral therapy]. (1999) (3)
- Influenza vaccination in HBsAg positive chronic active hepatitis patients treated with interferon (2005) (3)
- In vivo experiments with powder charcoal haemoperfusion (filmadsorber) in a pig model of hepatic failure. (1985) (3)
- 203 Combined cytolytic and noncytolytic intrahepatic CD8 T-lymphocyte reactivity is important for response to antiviral therapy in chronic hepatitis B patients (2003) (3)
- Effectiveness of interferon alfa on the clinical course of caucasian patients with viral compensated cirrhosis (1996) (3)
- Switching lamivudine resistant chronic Hepatitis B patients from tenofovir to adefovir results in less potent HBV DNA suppression (2006) (2)
- High frequency of lithogenic bile in primary biliary cirrhosis. (1982) (2)
- Differential effects of exogenous fibroblast and leucocyte interferon in HBsAg chronic hepatitis (1978) (2)
- 12 Hepatitis C and cirrhosis (2000) (2)
- Auxiliary transplantation of a partially hepatectomized liver in pigs with fulminant hepatic failure. (1984) (2)
- Human leucocyte antigens (HLA) in neonates with an inadequate response to hepatitis B vaccination. (1993) (2)
- [The treatment of hepatitis C]. (2003) (2)
- A randomized controlled trial evaluating therapy with ursodeoxycholic acid in daily doses of 10 mg/kg versus 20 mg/kg in primary biliary cirrhosis (1998) (2)
- Morbidity and mortality in compensated cirrhosis type C: relationship to interferon alpha therapy (1997) (2)
- 426 Paired measurements of quantitative hepatitis B virus DNA in saliva, urine and serum of chronic hepatitis B patients (2004) (2)
- Causes of death in fulminant hepatic failure. A guide to future management. (1986) (2)
- [Favorable results of auxiliary heterotopic liver transplantation in patients with end-stage chronic liver insufficiency]. (1991) (2)
- [Alpha-interferon antiviral treatment in 100 patients with chronic hepatitis B]. (1992) (2)
- 447 Liver histology in chronic hepatitis B patients after 1 year of treatment with pegylated interferon alpha-2B in combination with lamivudine or placebo (2004) (2)
- Disturbed liver function in heart transplantation candidates: two case reports. (1989) (2)
- Immunogenicity of two different dosages (10 and 5 micrograms) of recombinant DNA hepatitis B vaccine in healthy neonates. (1994) (2)
- HEPATITIS B: PREVACCINATION SCREENING OF INDIVIDUALS SIMULTANEOUSLY POSITIVE FOR HBsAg AND ANTI-HBs IN ONE ASSAY (1983) (2)
- Viral kinetics of the hepatitis C virus in patients treated with high dose daily combination therapy (1998) (2)
- Treatment of chronic viral hepatitis anno 1990. (1990) (2)
- Chronic HBV treatment with one year of pegylatyed-interferon alpha-2b (PEG-IFN) has a comparable safety profile to short term conventional interferon alpha-2b (2003) (2)
- Orthotopic liver transplantation: An experimental study on the prevention of infections with Gram‐negative organisms (1975) (2)
- Heterotopic auxiliary liver transplantation. 3. Functional competition--cause of atrophy of the auxiliary liver transplant. (1966) (2)
- Hepatitis B virus genotypes and response to interferon alpha treatment in chronic hepatitis B. (2001) (2)
- Impact of disease severity on outcome of antiviral therapy in treatment‐naïve patients with chronic hepatitis C (2007) (2)
- [Benign liver tumors and oral contraceptives: diagnosis and treatment]. (1986) (1)
- [Antiviral combination therapy in chronic hepatitis B]. (1987) (1)
- Hemofiltration in Acute Liver Failure: Substition with Electrolyte Solution Versus Normal Animal Ultrafiltrate (1981) (1)
- The antiviral effect of repeated courses of alpha interferon treatment in chronic hepatitis B (1991) (1)
- Treatment of chronic viral hepatitis anno 1990. (1992) (1)
- Treatment of chronic hepatitis type virus B. (1984) (1)
- Auxiliary partial liver transplantation: imaging evaluation in 10 patients. (1989) (1)
- Anti-pre-S(2) analysis after hepatitis B vaccination in haemodialysis patients. (1989) (1)
- Hepatitis B viral dynamics during four weeks of lamivudine: 150 mg versus 600 mg (1998) (1)
- Course of hepatitis delta virus infection in auxiliary liver grafts in patients with delta virus cirrhosis. (1991) (1)
- High sustained virological response in difficult to treat hepatitis C patients by combination of daily high dose and prolonged maintenance interferon-ribavirin therapy (2001) (1)
- Large-pore hemodialytic procedures in pigs with ischemic hepatic necrosis; a randomized study. (1984) (1)
- Liver preservation without perfusion. (1972) (1)
- Quantitative assay of hepatitis B surface antigen and DNA polymerase activity. (1979) (1)
- [The course of hepatitis B in 9 children who became positive for viral surface antigen HBsAg in spite of vaccination]. (1993) (1)
- Long term follow-up of glycyrrhizin therapy in patients with chronic hepatitis C and non-response to interferon: Meta-analysis of individual patient data (2003) (1)
- [Portal vein thrombosis: causes and treatment]. (1999) (1)
- Treatment of chronic hepatitis B with a combination of acyclovir and alpha-lymphoblastoid interferon. (1989) (1)
- Baseline anti-NS4a antibodies in combination with on-treatment quantitative HCV-RNA reliably identifies nonresponders to pegylated interferon–ribavirin combination therapy after 4 weeks of treatment (2010) (1)
- The results of a randomized controlled trial evaluating tips andendoscopic therapy in cirrhotic patients with gastro-esophagealvariceal bleeding (2000) (1)
- Diagnosis of subclinical hepatic encephalopathy: Spectral-leg versus standard psychometric tests (1995) (1)
- Interferon-alpha therapy in chronic hepatitis B: early monitoring of HBeAg may help to decide whether to stop or to prolong therapy (1999) (1)
- Treatment of chronic hepatitis B with a combination of acyclovir and human lymphoblastoid interferon. (1988) (1)
- [Lamivudine for the prevention of chronic hepatitis B exacerbations during chemotherapy for non-Hodgkin's lymphoma]. (2002) (1)
- Hepatitis B transmission among heart transplant recipients: an underestimated risk? (1996) (1)
- Interferon (IFN)– g –Inducible Protein–10: Association with Histological Results, Viral Kinetics, and Outcome during Treatment with Pegylated IFN- a 2a and Ribavirin for Chronic Hepatitis C Virus Infection (2006) (1)
- The results of a randomized controlled trial evaluating TIPS and endoscopic therapy in cirrhotic patients with gastro-esophageal variceal bleeding (1999) (1)
- Hepatitis C virus genotype and clinical outcome of compensated cirrhosis type C (1998) (1)
- Initial non-response to interferon in chronic hepatitis C: induction of ALT normalization and HCV-RNA disappearance by high-dose interferon therapy (1992) (1)
- 936 Distinct intrahepatic immunological environment in chronic viral hepatitis analysed by flow cytometry of fine-needle-aspiration-biopsies (2003) (1)
- [Hepatitis B virus infection in women treated with in-vitro fertilization]. (1989) (1)
- [Treatment of patients with gallstones with chenodeoxycholic acid]. (1978) (1)
- Prognosis in PBC: Who should we believe? (1990) (1)
- Survival and prognostic indicators in cryptogenic compensated cirrhosis: a multicenter study (1995) (1)
- 1145 Lamivudine treatment during pregnancy to prevent perinatal transmission of hepatitis B virus infection (2003) (1)
- [Premature infants and hepatitis B vaccination. Study Group Prevention Neonatal Hepatitis B]. (1992) (1)
- Letter: Treatment of cirrhosis with prednisone. (1975) (1)
- Relapse in HBeAg-positive chronic hepatitis B after Peg-Interferon alpha-2b therapy alone or in combination with lamivudine (2006) (1)
- Effect of antiviral therapy for chronic viral hepatitis on patient survival (2001) (1)
- 340 Glycyrrhizin given as stronger neominophagen C (SNMC) for the treatment of chronic hepatitis C: biochemical and histological effects after 26 weeks of treatment (2003) (1)
- 494 Analysis of peripheral HCV-specific T cell responses associated with rapid viral decline during PEG-interferon-alfa-2A and ribavirin therapy (DITTO-HCV project) (2004) (1)
- Chronic hepatitis B: diagnosis and treatment. (1986) (1)
- Failure of conventional treatment to prevent relapse of hepatic amoebiasis. (1981) (1)
- [LeVeen's peritoneojugular shunt for the treatment of ascites]. (1982) (0)
- to limit a hepatitis B epidemic among women undergoing in vitro fertilization (1991) (0)
- Hepatitis B vaccination in drug addicts and Down's syndrome patients (1983) (0)
- [Criteria for and results of liver transplantation in patients with acute liver insufficiency]. (1994) (0)
- The prognosis of viral compensated cirrhosis (2000) (0)
- Comparison of morbidity and mortality in HBsAg positive cirrhosis with or without hepatitis delta virus superinfection (1998) (0)
- Analysis of an epidemic hepatitis B infection among heart transplant recipients by automated sequence analysis (1996) (0)
- Ciclosporin Therapy in Primary Biliary Cirrhosis (PBC): A Pilot Study in 10 Patients (1985) (0)
- [A patient with liver disease and cyanosis]. (1972) (0)
- Prolonged intermittent treatment with interferon in chronic hepatitis B (1990) (0)
- Efficacy of interferon-alpha for the treatment of lamivudine resistant chronic HBeAg-positive Hepatitis B virus infection. (2006) (0)
- The natural history of chronic hepatitis C: a model bridging controversies. (1999) (0)
- [AIDS and HIV-infection as occupational disease]. (1993) (0)
- Glutamate neurotransmission during acute hepatic failure and acute hyperammonemia (1991) (0)
- Viral kinetics in patients with hepatitis C genotype 1, treated with high-dose daily interferon, high-dose pegylated interferon and pegylated interferon combined with daily interferon (2006) (0)
- CorrespondenceStudies of experimental hepatic encephalopathy (1985) (0)
- Selection of asymptomatic HIV carriers for antiviral therapy. (1990) (0)
- Immune response after vaccination with two hepatitis B vaccines differing in antigenic composition. (1983) (0)
- Steatosis does not affect the result of antiviral treatment in HCV genotype 3 infected patients (2005) (0)
- Blood ammonia level. (1979) (0)
- Should Helicobacter pylori be considered as a risk factor for hepatic encephalopathy in patients with liver cirrhosis (1996) (0)
- [Liver transplantation in acute liver insufficiency: definitive replacement or auxiliary liver?]. (1991) (0)
- The optimal treatment strategy for chronic hepatitis C. (2005) (0)
- [654] PREDICTION OF VIROLOGIC RESPONSE IN HCV GENOTYPE 1A-INFECTED PATIENTS ACCORDING TO AMINO ACID PATTERN IN NS5A USING STATISTICAL LEARNING ALGORITHMS FOR CLASSIFICATION (2007) (0)
- Up to date treatment of hepatitis C in adults. (1998) (0)
- beta 2-Microglobulin and antiviral therapy for chronic hepatitis type B. (1989) (0)
- Effectiveness of interferon alfa in caucasian patients with viral compensated cirrhosis (1997) (0)
- Clinical course of compensated cirrhosis type B: a European multicenter study (1992) (0)
- [Acute liver insufficiency: progress in liver function substitution]. (1980) (0)
- 971 Long term follow up of sustained responders to interferon alpha in chronic hepatitis C: a meta-analysis assessing true clinical endpoints (2003) (0)
- Viral kinetics in HCV genotype 1. Is the second phase of viral decline interferon dose dependent (1999) (0)
- Application of the KICA breath test analysis to detect mitochondrial toxicity in patients with chronic hepatitis B virus infection treated with the new nucleoside analogue, Lamivudine (1995) (0)
- [Current insights in the treatment of primary biliary cirrhosis]. (1978) (0)
- Recurrent bleeding fromcutaneous venouscollaterals inportal hypertension (1988) (0)
- [504] SWITCHING LAMIVUDINE RESISTANT CHRONIC HEPATITIS B PATIENTS FROM TENOFOVIR TO ADEFOVIR RESULTS IN HBVDNA RELAPSE WITHOUT EVIDENCE OF GENOTYPIC RESISTANCE (2007) (0)
- Cryoglobulins in primary biliary cirrhosis: prevalence and modulation by immunosuppressive therapy. (1985) (0)
- [A uniform protocol for liver transplantation in adults in The Netherlands]. (1997) (0)
- [Hepatitis B immunization in Dutch hospitals]. (1985) (0)
- Hepatocellular carcinoma (HCC) in cirrhosis type B: risk factors in 366 western european patients (1993) (0)
- PIN36 SCREENING OF MIGRANTS FOR CHRONIC HEPATITIS B VIRUS INFECTION: A COST-EFFECTIVENESS ANALYSIS (2009) (0)
- Detection ofHepatitis C VirusRNA inPatients withChronic Hepatitis C VirusInfections during andafter Therapy withAlphaInterferon (1993) (0)
- Hepatitis C virus genotype and prognosis of compensated cirrhosis type C (1999) (0)
- Non‐immunological parameters limiting extracorporal liver perfusion (1998) (0)
- Primary biliary cirrhosis: a changing clinical presentation. (1981) (0)
- [Current viewpoints in the drug therapy of gallstones]. (1983) (0)
- [Hepatitis B immunoprophylaxis; vaccination of newborn infants]. (1984) (0)
- [Combined passive and active immunization of infants of HbsAg-positive mothers]. (1985) (0)
- [Iatrogenic mental decompensation after detection of hepatitis antigen carrier state]. (1980) (0)
- [Acute liver insufficiency caused by rifampicin-isoniazid]. (1980) (0)
- Is there a role for interferon-a monotherapy in HBsAg and anti-HBe positive chronic hepatitis B? (1999) (0)
- Chronic hepatitis C: For what patients therapy is useful? (2005) (0)
- Round table discussion on future developments (1986) (0)
- [Hepatitis C in Egypt, a iatrogenic epidemic]. (2000) (0)
- P1889 Pharmacokinetic profiles in chronic hepatitis C patients treated with high-dose pegylated interferon (2007) (0)
- Mortality and morbidity in cryptogenic (type C) compensated cirrhosis: a multicenter study (1995) (0)
- Which patients with liver cirrhosis and hyperammonaemia develop encephalopathy (1996) (0)
- Cyclosporine in auxiliary partial liver transplantation. (1988) (0)
- [Transmission of hepatitis B virus by a surgeon]. (2000) (0)
- Prediction of response based on viral decline during PEG-interferon alpha-2b therapy in HBeAg-positive chronic hepatitis B (2006) (0)
- Antiviral combination therapy of alpha interferon and zidovudine in chronic hepatitis type b results from a randomized controlled trial (1991) (0)
- 620 Presence of CD4-positive cells in the portal tract on pretreatment liver biopsy is associated with early viral reduction during antiviral treatment of HCV (2006) (0)
- [Prevention of hemorrhages in esophageal varices]. (1988) (0)
- 955 The predictive value of intrahepatic CD8 T-lymphocytes and HBV core expression in relation to response to antiviral therapy for chronic hepatitis B patients (2003) (0)
- Modelling of viral decline and rebound in chronic hepatitis B patients during entecavir treatment (2001) (0)
- Hepatitis C virus genotype and risk of hepatocellular carcinoma in compensated cirrhosis type C (1998) (0)
- Transplantation: Imaging Evaluation in 10 Patients (1989) (0)
- 427 Viral dynamics with frequent sampling during tenofovir therapy in patients with lamivudine-resistant hepatitis B virus mutants (2004) (0)
- Co-occurrence of HBsAg and heterotypic anti-HBs (1981) (0)
- 1348 VIRAL HETEROGENEITY IN HCV NS5A GENOME IS LOW IN PATIENTS WITH FAVORABLE IL28B GENOTYPES (2011) (0)
- Chronic HCV: viral kinetics and duration of therapy (1998) (0)
- 31 Acute Hepatic Failure (1992) (0)
- [Antiviral therapy in chronic hepatitis B: wishful thinking or reality?]. (1987) (0)
- [Current recommendations on planning of liver transplantations in The Netherlands: the price of lagging behind]. (1994) (0)
- Clinical presentation and diagnostic features of patients with hepatocellular carcinoma (1996) (0)
- [The physician and the yellow girl]. (1988) (0)
- Current therapy of hepatitis C (2005) (0)
- [Health Council report 'Protection against hepatitis B': an opportunity for effective prevention through cooperation]. (1997) (0)
- , infection : a randomised trial treatment of patients with chronic hepatitis B Lamivudine and alpha interferon combination (2000) (0)
- [Chronic hepatitis C in hemodialysis patients]. (1997) (0)
- Hepatitis D virus (HDV)-related cirrhosis: a case-control study (1994) (0)
- [Possibilities and limitations of heterotopic auxiliary liver transplantation]. (1990) (0)
- Antibodies to E1 and E2 in patients infected with HCV1b : evolution of antibody levels after interferon therapy (1997) (0)
- 1146 Response to alpha-interferon prolongs survival and reduces the risk of hepatocellular carcinoma in chronic hepatitis B (2003) (0)
- Contrasting features andresponsestotreatment ofseverechronic active liver disease withand without hepatitis B.antigen (1976) (0)
- Bilirubin Volume 1 Chemistry and Volume 2 Metabolism (1983) (0)
- Combination of IFNa2b and isoprinosine in treatment of CHC: A pilotstudy (2000) (0)
- [Hepatitis B vaccine: accused but exonerated]. (1983) (0)
- Delayed viral decline is associated with highest sustained response rate during PEG-interferon treatment for HBeAg-positive chronic hepatitis B (2006) (0)
- Aetiology of liver cirrhosis as observed in a tertiary liver referral centre (1995) (0)
- Single dose or multiple doses of ursodeoxycholic acid (UDCA) are equally effective in the treatment of primary sclerosing cholangitis (PSC) and primary biliary cirrhosis (PBC) (1995) (0)
- Serum HBsAg loss in compensated cirrhosis B: relation to interferon alpha therapy and liver disease prognosis (1998) (0)
- Liver Disease Symptom Index Version 2.0 (2017) (0)
- Prevention of hepatitis B by recombinant DNA hepatitis B vaccine. (1986) (0)
- [Hepatitis B virus in schools; a risk?]. (1991) (0)
- Studies of experimental hepatic encephalopathy (1985) (0)
- Hepatitis B. (2018) (0)
- Pretreatment intrahepatic CD8+ cell number correlates with virological response to antiviral therapy in chronic hepatitis C (2003) (0)
- 958 Hepatitis B virus genotypes in HBEAG-positive patients: geographic distribution and relation to viral replication and fibrosis (2003) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Solko W. Schalm?
Solko W. Schalm is affiliated with the following schools:
